Paulina Carriba

Dr. Paulina Carriba

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2008 in Nature Methods
Verified
Journal Article
Closed access
PCPaulina Carriba
Paulina Carriba
GNGemma Navarro
Gemma Navarro
FCFrancisco Ciruela
Francisco Ciruela
SFSergi Ferre
Sergi Ferre
VCVicent Casadó
Vicent Casadó
Rafael FrancoRafael Franco
Rafael Franco

14 March 2007 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PCPaulina Carriba
Paulina Carriba
OOOskar Ortiz
Oskar Ortiz
KPKshitij Patkar
Kshitij Patkar
ZJZuzana Justinova
Zuzana Justinova
JSJessica Stroik
Jessica Stroik
SFSergi Ferre
Sergi Ferre

1 April 2008 in Neuropharmacology
Verified
Journal Article
Closed access
DMDaniel James Marcellino
Daniel James Marcellino
PCPaulina Carriba
Paulina Carriba
MFMałgorzata Filip
Małgorzata Filip
ABAnders Borgkvist
Anders Borgkvist
MFMalgorzata Frankowska
Malgorzata Frankowska
KFKjell Fuxe
Kjell Fuxe

19 October 2006 in Journal of Proteome Research
Verified
Journal Article
Closed access
LALuigi F. Agnati
Luigi F. Agnati
SFSergi Ferre
Sergi Ferre
SGSusanna Genedani
Susanna Genedani
GLGiuseppina Leo
Giuseppina Leo
Diego GuidolinDiego Guidolin
Diego Guidolin
KFKjell Fuxe
Kjell Fuxe

3 August 2016 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
LPLaura Planells‐Ferrer
Laura Planells‐Ferrer
JUJorge Urresti
Jorge Urresti
ECElena Coccia
Elena Coccia
KGKoen M. O. Galenkamp
Koen M. O. Galenkamp
ICIsabel Calleja‐Yagüe
Isabel Calleja‐Yagüe
JCJoan X. Comella
Joan X. Comella

12 February 2015 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
PCPaulina Carriba
Paulina Carriba
SJS Jimenez
S Jimenez
VNV Navarro
V Navarro
Ines Moreno-GonzalezInes Moreno-Gonzalez
Ines Moreno-Gonzalez
BBB Barneda-Zahonero
B Barneda-Zahonero
JCJ X Comella
J X Comella
The brains of patients with Alzheimer’s disease (AD) present elevated levels of tumor necrosis factor-α (TNFα), a cytokine that has a dual function in neuronal cells. On one hand, TNFα can activate neuronal apoptosis, and on the other hand, it can protect these cells against amyloid-β (Aβ) toxicity. Given the dual behavior of this molecule, there is some controversy regarding its contribution to the pathogenesis of AD. Here we examined the relevance of the long form of Fas apoptotic inhibitory molecule (FAIM) protein, FAIM-L, in regulating the dual function of TNFα. We detected that FAIM-L was reduced in the hippocampi of patients with AD. We also observed that the entorhinal and hippocampal cortex of a mouse model of AD (PS1M146LxAPP751sl) showed a reduction in this protein before the onset of neurodegeneration. Notably, cultured neurons treated with the cortical soluble fractions of these animals showed a decrease in endogenous FAIM-L, an effect that is mimicked by the treatment with Aβ-derived diffusible ligands (ADDLs). The reduction in the expression of FAIM-L is associated with the progression of the neurodegeneration by changing the inflammatory response mediated by TNFα in neurons. In this sense, we also demonstrate that the protection afforded by TNFα against Aβ toxicity ceases when endogenous FAIM-L is reduced by short hairpin RNA (shRNA) or by treatment with ADDLs. All together, these results support the notion that levels of FAIM-L contribute to determine the protective or deleterious effect of TNFα in neuronal cells.